Biochemical and therapeutic effects of Omega-3 fatty acids in sickle cell disease.
Biochemical and therapeutic effects of Omega-3 fatty acids in sickle cell disease.
Complement Ther Med. 2020 Aug;52:102482
Authors: Daak AA, Lopez-Toledano MA, Heeney MM
Abstract
Sickle cell disease (SCD) is a hematologic disorder with complex pathophysiology that includes chronic hemolysis, vaso-occlusion and inflammation. Increased leukocyte-erythrocyte-endothelial interactions, due to upregulated expression of adhesion molecules and activated endothelium, are thought to play a primary role in initiation and progression of SCD vaso-occlusive crisis and end-organ damage. Several new pathophysiology-based therapeutic options for SCD are being developed, chiefly targeting the inflammatory pathways. Omega-3 fatty acids are polyunsaturated fatty acids that are known to have effects on diverse physiological processes. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the principal biologically active omega-3 fatty acids. The therapeutic effects of DHA and EPA on chronic inflammatory disorders and cardiovascular diseases are well recognized. The therapeutic effects of omega-3 fatty acids are attributed to their anti-inflammatory and anti-thrombotic eicosanoids, and the novel class of EPA and DHA derived lipid mediators: resolvins, protectins and maresins. Blood cell membranes of patients with SCD have abnormal fatty acids composition characterized by high ratio of pro-inflammatory arachidonic acid (AA) to anti-inflammatory DH...
Source: Complementary Therapies in Medicine - Category: Complementary Medicine Authors: Daak AA, Lopez-Toledano MA, Heeney MM Tags: Complement Ther Med Source Type: research
More News: Alternative and Complementary Therapies | Cardiology | Cardiovascular | Complementary Medicine | Heart | Hematology | Omega 3 | Omega 6 | Sickle Cell Anemia | Study